Caxton Associates LP Dexcom Inc Transaction History

Caxton Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $238,492 - $330,057	-2,535 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $329,220 - $412,748	2,535 New	2,535 $1.36 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $74,880 - $100,320	-960 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $91,689 - $108,432	960 New	960 $396,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $125,673 - $211,206	-2,005 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $95,818 - $151,638	2,005 New	2,005 $540,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.